small molecule

MEN'S ROGAINE

MINOXIDIL

Loss of exclusivity—loss of exclusivity
CompanyKENVUE BRANDS LLC

Drug detail

Brand nameMEN'S ROGAINE
Active ingredientMINOXIDIL
Strength5%
Dosage formAEROSOL, FOAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalJanuary 2006
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.